Indication

Klebsiella endometritis

Klebsiella endometritis refers to an infectious inflammatory condition of the endometrium, the inner epithelial lining of the uterus, caused by the Gram-negative bacillus *Klebsiella* (predominantly *Klebsiella pneumoniae*). Read more about Klebsiella endometritis

17 drugs 14 manufacturers

Advertisement

Drugs that treat it

Common Klebsiella endometritis therapies.

Showing 1–9 of 17 drugs

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP PHARMACEUTI

AZTREONAM

SEPSIS CAUSED BY ENTEROBACTER·+57
APP/PREMIERPRO

AZTREONAM

BETA-LACTAMS·SEPSIS CAUSED BY ENTEROBACTER·+57
APP/NOVAPLUS
Filter & compare in the drug finder →Opens the drug finder with Klebsiella endometritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Klebsiella endometritis.

Klebsiella endometritis refers to an infectious inflammatory condition of the endometrium, the inner epithelial lining of the uterus, caused by the Gram-negative bacillus *Klebsiella* (predominantly *Klebsiella pneumoniae*).

It typically affects women of reproductive age, most commonly arising as a component of postpartum endomyometritis following labor or cesarean delivery, or after invasive intrauterine gynecologic procedures.

Pathophysiologically, the organism ascends from the lower genital tract or perineal flora into the uterine cavity, triggering mucosal inflammation characterized by neutrophilic infiltration or plasma cell proliferation.

Clinically, affected patients often present with fever, lower abdominal and pelvic pain, uterine tenderness, and abnormal or malodorous vaginal discharge, with potential complications including pelvic abscess, peritonitis, sepsis, and impaired future fertility if untreated.

Personalize your experience

Follow Klebsiella endometritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it